Multimedia Aid for Genetic Testing in Gynecologic Oncology
1 other identifier
interventional
30
1 country
1
Brief Summary
This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted. Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2024
CompletedFirst Submitted
Initial submission to the registry
July 16, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
November 12, 2025
November 1, 2025
2.1 years
July 16, 2025
November 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of genetic testing
Proportion of eligible patients undergoing any genetic testing before and after the implementation of educational videos.
Baseline
Secondary Outcomes (2)
Overall rates of genetic testing
Baseline
Patient satisfaction
Baseline
Study Arms (1)
Genetic Testing Awarness
EXPERIMENTALEducational videos about genetic testing will be provided for ovarian cancer and endometrial cancer.
Interventions
Educational videos about genetic testing will be provided. Subjects will be asked to view one of three videos (an endometrial cancer/Lynch Syndrome video or a longer or shorter version of an ovarian cancer video) relevant to their cancer diagnosis and genetic testing.
Subjects will be asked to complete a brief satisfaction survey.
Eligibility Criteria
You may qualify if:
- In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
- Reviewed informed consent to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 18 years at the time of consent.
- Diagnosis of ovarian cancer or endometrial cancer
- Eligible for genetic testing
- English or Spanish is the primary language
You may not qualify if:
- Previously completed genetic testing
- Did not receive initial cancer-directed treatment at study site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Tucker, MD
UNC Lineberger Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2025
First Posted
July 24, 2025
Study Start
October 10, 2024
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
November 12, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share